Integra LifeSciences Reports First Quarter 2026 Financial Results
Integra LifeSciences Holdings Corporation reported its financial results for Q1 2026, showing a 2.4% increase in total revenues to $391.9 million and improved gross margins. Despite a GAAP net loss of $(4.6) million, the company showcased strong performance in its Tissue Reconstruction segment and provided a positive outlook for the upcoming quarters.
PRINCETON, N.J., May 05, 2026 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today reported financial results for the first quarter ending March 31, 2026.